位置:首页 > 产品库 > Vecuronium Bromide(ORG NC 45)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Vecuronium Bromide(ORG NC 45)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Vecuronium Bromide(ORG NC 45)图片
CAS NO:50700-72-6
规格:≥98%
包装与价格:
包装价格(元)
10mg询价
25mg询价
50mg询价
100mg询价
250mg询价
500mg询价
1g询价

理化性质和储存条件
Molecular Weight (MW)637.73
FormulaC34H57N2O4.Br
CAS No.50700-72-6
Storage-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)DMSO: 100 mg/mL (156.8 mM)
Water: 4 mg/mL (6.3 mM)
Ethanol: 100 mg/mL (156.8 mM)
Other info
Chemical Name: 1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17S)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium bromide
InChi Key: VEPSYABRBFXYIB-WSIGYWTFSA-M
InChi Code: InChI=1S/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32+,33-,34-;/m0./s1
SMILES Code: CC(O[C@@H]1[C@@H](N2CCCCC2)C[C@]3(C)[C@@]4([H])CC[C@]5(C)[C@H](OC(C)=O)[C@@H]([N+]6(C)CCCCC6)C[C@@]5([H])[C@]4([H])CC[C@@]3([H])C1)=O.[Br-]
SynonymsORG NC45; C 45; NC-45; NC45; ORG NC 45; ORG NC45; ORG-NC 45; ORG-NC-45; ORG-NC45; ORGNC 45; ORGNC45; Vecuronium bromide. Brand name Norcuron
实验参考方法
In Vitro

In vitro activity: Vecuronium inhibits both forms of the muscle-type acetylcholine receptor with IC50 of 1-2 mM. Vecuronium combined with methylprednisolone shows additive effects on both receptor forms, which is best described by a two-site model, with each site independent. Vecuronium interferes with nicotinic processes in the carotid body and inhibits the chemoreceptor neural response to hypoxia. Vecuronium significantly attenuates the increase in CSNA (DeltaCSNA) in response to hypoxia in the carotid body.

In VivoVecuronium (a monoquaternary ammonium compound) has a higher biliary clearance than pancuronium (a bisquaternary ammonium compound) in the rats.
Animal modelRats
Formulation & DosageN/A
ReferencesAnesthesiology. 2000 Mar;92(3):821-32; Anesth Analg. 2002 Jan;94(1):117-22; Anesth Analg. 1982 Apr;61(4):313-6.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024